Nonsteroidal MRA in T2D-associated CKD

Share

Program Content

Activities

  • Slides: MRA in T2D CKD
    Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

    View Activity
  • MRA in T2D CKD
    Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2022

    Expires: August 03, 2023

    View Activity
  • Finerenone in T2D CKD
    Evidence for Use of Finerenone in T2D-associated CKD
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2022

    Expires: August 03, 2023

    View Activity

Faculty

cover img faculity

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

cover img faculity

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP

Vice Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
Spokane, Washington

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim and Eli Lilly